Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topotecan in Recurrent Platinum-Sensitive Ovarian or Primary Peritoneal Cancer
NCT00005029Phase 2Terminated
- Sponsor
- GOG Foundation
- Start
- Feb 2000
- Primary completion
- Jan 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of topotecan in ovarian cancer, primary peritoneal cancer (PPC), sponsored by GOG Foundation. Started Feb 2000; status: terminated.
02
Drugs
topotecan
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00005029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005029.